Biotechnology - NicOx

Filter

Current filters:

NicOx

Popular Filters

NicOx to acquire Aciex Therapeutics

02-07-2014

Ophthalmology-focused French biotech firm NicOx has entered into an agreement to acquire all of the outstanding…

Aciex TherapeuticsBiotechnologyInflammatory diseasesMergers & AcquisitionsNicOxOphthalmics

NicOx launches commercial operations in Germany

30-06-2014

Ophthalmology-focused French biotech firm NicOx has today announced the launch of its German operations.

AdenoPlusBiotechnologyGermanyManagementMarkets & MarketingNicOxOphthalmicsXailin

NicOx appoints financial partner to assess Duchenne Muscular Dystrophy treatment

14-02-2014

French biotechnology firm NicOx (Euronext Paris: COX) has granted an undisclosed financial partner an…

BiotechnologyFranceGeneticsLicensingnaproxcinodNicOx

Nicox granted exclusive promotion and marketing rights for AMD test in North America

17-01-2014

French biotech firm NicOx SA (NYSE Euronext Paris: COX) and USA-based Sequenom (Nasdaq: SQNM) have entered…

BiotechnologyFranceLicensingNicOxOphthalmicsSequenomUSA

NicOx highlights progress in bid to focus on ophthalmology

07-01-2014

French biotech firm NicOx SA (NYSE Euronext Paris: COX) says it has made significant progress in 2013…

BiotechnologyFinancialFranceNicOxOphthalmics

NicOx drops its option to take full ownership of Altacor

04-06-2012

French biotechnology firm NicOx (NYSE Euronext Paris: COX) said last Friday that its board of directors…

AltacorBiotechnologyMergers & AcquisitionsNicOxOphthalmics

NicOx takes option to buy UK ophthalmic company

22-03-2012

French biotechnology firm NicOx (Euronext Paris: COX) has entered into an agreement to acquire 11.8%…

AltacorBiotechnologyMergers & AcquisitionsNicOxOphthalmicsPharmaceutical

NicOx earns $10M milestone under Bausch & Lomb accord

13-03-2012

French biotechnology firm NicOx (Euronext Paris: COX) will receive a $10 million milestone from US partner…

Bausch & LombBiotechnologyFinancialNicOxOphthalmicsPharmaceuticalResearch

Parexel

Parexel

Back to top